2017 Sec 1 Green Book

231 / 232

n engl j med 372;8 february 19, 2015
Oral Propranolol in Infantile Hemangioma
treatment of periocular infantile heman-
giomas with oral propranolol. J AAPOS
2010;14:251-6.
33. Snir M, Reich U, Siegel R, et al. Re-
fractive and structural changes in infan-
tile periocular capillary haemangioma
treated with propranolol. Eye (Lond) 2011;
25:1627-34.
34. Fuchsmann C, Quintal MC, Giguere C,
et al. Propranolol as first-line treatment
of head and neck hemangiomas. Arch
Otolaryngol Head Neck Surg 2011;137:
471-8.
35. Mazereeuw-Hautier J, Hoeger PH,
Benlahrech S, et al. Efficacy of proprano-
lol in hepatic infantile hemangiomas with
diffuse neonatal hemangiomatosis. J Pe-
diatr 2010;157:340-2.
36. Metry D, Frieden IJ, Hess C, et al. Pro-
pranolol use in PHACE syndrome with
cervical and intracranial arterial anoma-
lies: collective experience in 32 infants.
Pediatr Dermatol 2013;30:71-89.
37. Phillips RJ, Penington AJ, Bekhor PS,
Crock CM. Use of propranolol for treat-
ment of infantile haemangiomas in an
outpatient setting. J Paediatr Child Health
2012;48:902-6.
Copyright © 2015 Massachusetts Medical Society.
209